A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol)

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 1, 1997, Pages 16-21

  Lundberg, Bo B ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CREMOPHOR; DIPALMITOYLPHOSPHATIDYLCHOLINE; DRUG VEHICLE; GLUCOSE; LIPID EMULSION; LIPOSOME; MACROGOL; PACLITAXEL; PHOSPHATIDYLETHANOLAMINE; POLYSORBATE 80; TRIOLEIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG UPTAKE; FREEZE DRYING; HUMAN; HUMAN CELL; PARENTERAL DRUG ADMINISTRATION; SIDE EFFECT;

EID: 0031033405     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06744.x     Document Type: Article

References (32)

1. Alkan-Onyuksel, H., Ramakrishnan, S., Chai, H. B., Pezzuto, J.M. (1994) A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm. Res. 11: 206-212
2. Allen, T. M., Hansen, C., Martin, F., Redemann, C., Yau-Young, A. (1991) Liposomes containing synthetic lipid derivatives of polyethylene glycol show prolonged circulation half-lives in vivo. Biochim. Biophys. Am 1066: 29-36
3. Balasubramanian, S. V., Straubinger, R. M. (1994) Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes. Biochemistry 33: 8941-8947
4. Balasubramanian, S. V., Alderfer, J. L., Straubinger, R. M. (1994) Solvent- and concentration-dependent molecular interactions of taxol (paclitaxel). J. Pharm. Sci. 83: 1470-1476
5. Hill, B. T., Whelan, R. D. H., Shellard, S. A., McClean, S., Hosking, L. K. (1994) Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant cell lines in vitro. Invest. New Drugs 12: 169-182
6. Holmes, F. A., Walters, R. S., Theriault, R. L., Forman, A. D., Newton, L. K., Raber, M. N., Buzdar, A. U., Frye, D. K., Hortobagyi, G. N. (1991) Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J. Natl Cancer Inst. 83: 1797-1805
7. Jain, R. K. (1989) Delivery of novel therapeutic agents in tumours: physiological barriers and strategies. J. Natl Cancer Inst. 81: 570-576
8. Liebmann, J. E., Cook, J. A., Lipscholtz, C., Teague, T., Fisher, J., Mitchell, J. B. (1993) Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br. J. Cancer 68: 1104-1109
9. Lundberg, B. (1987) Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway. Cancer Res. 47: 4105-4108
10. Lundberg, B. (1994) Preparation of drug-carrier emulsions stabilized with phosphatidylcholine-surfactant mixtures. J. Pharm. Sci. 83: 72-75
11. Lundberg, B. B., Mortimer, B.-C., Redgrave, T. G. (1996) Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carrier with prolonged circulation time. Int. J. Pharm. 134: 119-237
12. Maruyama, K., Yuda, T., Okamoto, A., Kojima, S., Suginaka, A., Iwatsuru, M. (1992) Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1128: 44-49
13. Markwell, M. A. K., Hass, S. M., Bieber, L. L., Tolbert, N. E. (1978) Modified Lowry procedure to simplify protein determination in membranous and lipoprotein samples. Anal. Biochem. 87: 206-210
14. Mathew, A. E., Mejillano, M. R., Nath, J. P., Himes, R. H., Stella, V. J. (1992) Synthesis and evaluation of some water-soluble pro-drugs and derivatives of taxol with antitumour activity. J. Med. Chem. 35: 145-151
15. Mayhew, E. G., Lasic, D., Babbar, S., Martin, F. J. (1992) Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int. J. Cancer 51: 302-309
16. Nygren, P., Csoka, K., Jonsson, B., Fridborg, H., Bergh, J., Hagberg, H., Glimelius, B., Brodin, O., Tholander, B., Kreuger, A., Lonnerholm, G., Jakobsson, A., Olsen, L., Kristensen, J., Larsson, R. (1995) The cytotoxic activity of axol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL. Br. J. Cancer 71: 478-481
17. Pelham, L. D. (1981) Rational use of intravenous fat emulsions. Am. J. Hosp. Pharm. 38: 198-208
18. Phillips, M. C., Johnson, W. J., Rothblat, G. H. (1987) Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta 906: 223-276
19. Rafaeloff, R., Husain, S. R., Rahman, A. (1992) Liposomes-encapsulated taxol (LET) is an effective modality to circumvent multidrug resistance (MDR) phenotype. Proc. Am. Assoc. Cancer Res. 33: 2883
20. Rensen, P. C. N., van Dijk, M. C. M., Havenaar, E. C., Bijsterbosch, M. K., Kruijt, J. K., van Berkel, T. J. C. (1995) Selective liver targeting of antivirals by recombinant chylomicrons - a new therapeutic approach to hepatitis B. Nature Med. 1: 221-225
21. Ringel, I., Horwitz, S. B. (1991) Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J. Natl Cancer Inst. 83: 288-291
22. Riondel, J., Jacrot, M., Fessi, H., Puisieux, F., Potier, P. (1992) Effects of free and liposome-encapsulated taxol on two brain tumors xenografted into nude mice. In Vivo 6: 23-27
23. Rose, W. C. (1992) Taxol: a review of its preclinical in vivo antitumor activity. Anti-Cancer Drugs 3: 311-321
24. Rubinstein, A., Pathak, Y. V., Kleinstern, J., Reches, A., Benita, S. (1991) In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsions. J. Pharm. Sci. 80: 643-647
25. Runowicz, C. D., Wiernik, P. H., Einzig, A. I., Goldberg, G. L., Horwitz, S. B. (1993) Taxol in ovarian cancer. Cancer 71: 1591-1596
26. Schiff, P. B., Horwitz, S. B. (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl Acad. Sci. USA 77: 1561-1565
27. Sculier, J. P., Coune, A., Rassinne, C. B., Laduran, C., Atassi, G., Ruysschaert, J. M., Fruhling, J. (1986) Intravenous infusion of high doses of liposomes containing NSC251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetics data. J. Clin. Oncol. 4: 789-797
28. Sharma, A., Straubinger, R. M. (1994) Novel taxol formulations: preparation and charaterization of taxol-containing liposomes. Pharm. Res. 11: 889-896
29. Sharma, A., Mayhew, E., Straubinger, R. M. (1993) Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res. 53: 5877-5881
30. Tarr, B. D., Sambandan, T. G., Yalkowsky, S. H. (1987) A new parenteral emulsion for the administration of taxol. Pharm. Res. 4: 162-165
31. Waugh, W. N., Trissel, L. A., Stella, V. J. (1991) Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am. J. Hosp. Practice 48: 1520-1524
32. Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., van Echo, D. A., von Hoff, D. D., Leyland-Jones, B. (1990) Hypersensitivity reactions from taxol. J. Clin. Oncol. 8: 1263-1268